During the Feasibility Study, we have analysed main key points to verify the viability of the Project from a technical, commercial and financial point of view.
Regarding Technical aspects, we defined the work plan to be implemented to better achieve the development and upgrade of NASALFLOW features necessary to reach the market launch status. In this sense, in addition to global improvements (especially the virtual surgery tool), the feasibility of forced breathing and particle dynamics models has been validated. Furthermore, the necessary framework has been defined to carry out the clinical tests that allow to verify the validity of NASALFLOW as a diagnostic and treatment tool.
Regarding the commercial section, we have carried out an extensive prospective analysis of the market for medical devices in the ENT area, anticipating trends and needs to be able to define a new market niche in which to place NASALFLOW, since we cannot fit it into a specific submarket.
In addition, given the novelty of our service, we have evaluated the different options to protect it from competitors, as well as the detailed study of the existing IPR barriers that enable us to operate in our target markets.
Finally, we have defined our commercial and dissemination policy for the project in order to involve the greatest number of stakeholders.
In relation with financial section, we have prepared 5-year financial projections in which the main conclusions derived from the technical and commercial sections have been taken into account, as well as we have estimated the required funding to undertake the project under these conditions. All this output data has allowed us to update the business plan of the project and offer mitigation solutions in case of unforeseen events.
